Point72 Asset Management, L.P. 13D/13G Filings for Krystal Biotech, Inc. (KRYS)

Point72 Asset Management, L.P. 13D and 13G filings for Krystal Biotech, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-14
4:02 pm
Sale
2022-12-3113GKrystal Biotech, Inc.
KRYS
Point72 Asset Management, L.P.556,252
2.200%
-1,304,418decrease
(-70.10%)
Filing
2022-02-14
4:49 pm
Purchase
2021-12-3113GKrystal Biotech, Inc.
KRYS
Point72 Asset Management, L.P.1,860,670
7.500%
517,428increase
(+38.52%)
Filing
2021-12-06
5:22 pm
Purchase
2021-12-0313GKrystal Biotech, Inc.
KRYS
Point72 Asset Management, L.P.1,343,242
5.400%
1,343,242increase
(New Position)
Filing